Abstract
Objective
To assess outcomes of ultrasound and physical examination-based cerclage performed at mid to late second trimester and to assess the potential added value of progesterone treatment combined with cerclage for preventing preterm birth.
Study design
A retrospective cohort study of women who underwent cerclage in a university-affiliated tertiary medical center (2012–2018). Inclusion criteria included only ultrasound-based cerclage and physical examination-based cerclage. Women who underwent history-based cerclage or multiple gestations were excluded. Study groups were stratified by previous PTB < 37 weeks and other risk factors for PTB. Primary outcome was the incidence of preterm birth < 35 weeks of gestation. Secondary outcomes included the potential added value of progesterone treatment and neonatal outcome.
Results
Sixty-nine women underwent cervical cerclage placement between 16–23 weeks of gestation. All women had short cervix (cervical length of < 25 mm) at presentation. Indications for cerclage placement included: 29% previous PTB, 32% prior cervical interventions (history of at least one D&C, hysteroscopy or cold-knife conization in the past), 22% had cervical dilatation > 1 cm at presentation, 12% due to failure of progesterone treatment defined as continued cervical shortening after 14 days of progesterone treatment, and 5% had other indications. Overall, 42 women (61%) gave birth at term. 27 women (39%) delivered prior to 37 weeks of gestation, of them, 20 women (29%) gave birth prior to 35 weeks. Overall median gestational age at delivery was 35 + 5 ± 4.7 weeks. Cervical dilatation at presentation of > 1 cm was associated with an increased risk for PTB < 35 weeks (OR 3.57, CI 1.43–30.81, p = 0.036). Previous PTB, prior cervical interventions and extent of cervical shortening at presentation did not increase the risk of PTB. Progesterone treatment in addition to cerclage did not result in a decreased risk for PTB < 35 weeks of gestation (OR 2.83, CI 0.58–13.89, p = 0.199).
Conclusion
Late second trimester cerclage is a practical measure for preventing PTB in cases of asymptomatic cervical shortening. Our study did not find adjunctive benefit for progesterone treatment with physical or ultrasound-based cerclage in reducing the rate PTB.
Similar content being viewed by others
References
Committee on Practice Bulletins—Obstetrics (2012) Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 120(4):964
Berghella V, Odibo AO, To MS et al (2005) Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 106(1):181–189
Owen J, Hankins G, Iams JD et al (2009) Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 201(4):375–e1
Berghella V, Ciardulli A, Rust OA et al (2017) Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol 50(5):569–577
Althuisius SM, Dekker GA, Hummel P et al (2001) Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 185(5):1106–1112
Macnaughton MC, Chalmers IG, Dubowitz V et al (1993) Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. BJOG: Int J Obstet Gynaecol 100(6):516–523
Berghella V, Odibo AO, Tolosa JE (2004) Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol 191(4):1311–1317
Althuisius SM, Dekker GA, Hummel P et al (2003) Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 189(4):907–910
Ventolini G, Neiger R (2008) Management of painless mid-trimester cervical dilatation: prophylactic vs emergency placement of cervical cerclage. J Obstet Gynaecol 28(1):24–27
Ehsanipoor RM, Seligman NS, Saccone G et al (2015) Physical examination–indicated cerclage: a systematic review and meta-analysis. Obstet Gynecol 126(1):125–135
Pereira L, Cotter A, Gómez R et al (2007) Expectant management compared with physical examination–indicated cerclage (EM-PEC) in selected women with a dilated cervix at 140/7-256/7 weeks: results from the EM-PEC international cohort study. Am J Obstet Gynecol 197(5):483–e1
Conde-Agudelo A, Romero R, Da Fonseca E et al (2018) Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Am J Obstet Gynecol 219(1):10–25
Romero R, Conde-Agudelo A, Da Fonseca E et al (2018) Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol 218(2):161–180
Hassan SS, Romero R, Vidyadhari D et al (2011) Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 38(1):18–31
Norman JE, Marlow N, Messow CM et al (2016) Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 387(10033):2106–2116
Szychowski JM, Berghella V, Owen J et al (2012) Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate. J Mater-Fetal Neonatal Med 25(12):2686–2689
Stetson B, Hibbard JU, Wilkins I et al (2016) Outcomes with cerclage alone compared with cerclage plus 17α-hydroxyprogesterone caproate. Obstet Gynecol 128(5):983–988
Sinkey RG, Garcia MR, Odibo AO (2018) Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth? J Matern-Fetal Neonatal Med 31(2):202–208
Rafael TJ, Mackeen AD, Berghella V (2011) The effect of 17a-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage. Am J Perinatol 28:389–94
Groom KM, Shennan AH, Bennett PR (2002) Ultrasound-indicated cervical cerclage: outcome depends on preoperative cervical length and presence of visible membranes at time of cerclage. Am J Obstet Gynecol 187(2):445–449
Berghella V, Ludmir J, Simonazzi G, Owen J (2013) Transvaginal cervical cerclage: evidence for perioperative management strategies. Am J Obstet Gynecol 209(3):181–192
Berghella V (2010) Every 30 seconds a baby dies of preterm birth. What are you doing about it? Am J Obstet Gynecol 203(5):416–417
Rebarber A, Cleary-Goldman J, Istwan NB et al (2008) The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage. Am J Perinatol 25:271–5
Berghella V, Figueroa D, Szychovski JM et al (2010) 17- alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 202(351):e1–e6
Funding
No funding for this study was needed.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We report no conflict of interest and no commercial association.
Ethical approval
The local ethics committee approved the study. This article has not been published and will not be submitted for publication elsewhere during the period of review.
Informed consent
No informed consent was needed due to the retrospective nature of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lavie, M., Shamir-Kaholi, N., Lavie, I. et al. Outcomes of ultrasound and physical-exam based cerclage: assessment of risk factors and the role of adjunctive progesterone in preventing preterm birth—a retrospective cohort study. Arch Gynecol Obstet 301, 981–986 (2020). https://doi.org/10.1007/s00404-020-05482-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05482-w